Promise Bio

Private

Tel AvivHealthcare & Life Scienceshttps://www.promise.bio/

Last Round

Seed

Dec 16, 2024

Total Funding Raised

$8.3M

Company Overview

Promise Bio is a biotechnology company that provides an artificial intelligence-based healthcare platform for epiproteomic analysis to treat immune-mediated diseases.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Precision Medicine, Biotechnology, Healthcare Analytics

Business Model

B2B

Customer Profile

Services & Consulting, Usage-Based SaaS

AI Layer

Application

Keywords

epiproteomicspost-translational modificationsPTMprecision medicinedrug discoverybiomarker discoverymass spectrometryAI drug discoveryproteomicscomputational biologybioinformaticspatient stratificationAI-powered platformdrug target identificationbiotech softwarein silico drug discovery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Promise Bio Comparables

Compare Promise Bio with similar companies based on industry and business-model similarity.

Promise Bio comparables — related companies by embedding similarity
Company	Similarity	Market Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

Promise Bio Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Seed	Dec 16, 2024

View all Funding Rounds

Key People

Founding team and executive leadership

Assaf Kacen

Co-Founder CTO

Founding Team

Ronel Veksler

Co-Founder CEO

Founding Team

Promise Bio Investors

Notable investors and investment history

Promise Bio investors
Investor	Rounds
Awz Ventures	Seed
Israel Innovation Authority	Seed
Israel Innovation Authority	Seed
Awz Ventures	Seed
Pfizer	Seed
AION Labs	Seed

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Mar 3, 2026
Monthly visitors increased 215% MoM.

View all signals

Promise Bio Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Promise Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Promise Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersTel Aviv

Employee Range14

Year Founded2024

Last FundingDec 16, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.